top of page

May 21, 2023

Farcast announces expansion of precision oncology research hubs

Farcast, a pioneer and leader in human tumor microdynamics research, having established its labs in Bengaluru in Southern India with head and neck squamous cell carcinoma, renal cell carcinoma and stomach adenocarcinoma is expanding the range of cancers to include breast, lung and gyn cancers.

May 23, 2022

Crosscope and Farcast Biosciences join efforts to reshape the precision oncology landscape via AI-powered pathology

Today marks the beginning of a new era in the field of cancer diagnosis and precision medicine with the coming together of two leading organizations Crosscope Inc., a Silicon Valley-based leader and provider of Vendor Agnostic AI-enabled Digital Pathology Platform, and Farcast Bioscience LLC, a Florida based Company.

bottom of page